Loading…
Portfolio as on Aug 2026 · 56 equity positions
Kotak Quant Fund is a Smart-Beta / Factor scheme managed by Kotak MF Mutual Fund. As of disclosures dated Aug 2026, the scheme holds 56 equity positions with an estimated equity AUM of ₹503.79 Cr. The portfolio is anchored by its top conviction bet on Sun Pharmaceutical Industries, which commands a weight of 3.44%of the fund's total assets.
From a sector allocation perspective, the fund managers have concentrated their largest bet on Pharmaceuticals & Biotechnology, representing 16.35% of the equity portfolio. This is followed by Industrial Products (12.31%) and Banks (8.22%). Under SEBI's guidelines and based on its underlying assets, this scheme carries a Very High Risk risk classification.
₹14.87 per unit -1.1% vs Oct '25
Last 365 days · daily NAV from AMFI · Kotak Quant Fund
Based on ~12 months of weekly NAV history from AMFI. Volatility is the annualized standard deviation of NAV returns. Sharpe ratio and alpha assume a 6.5% risk-free rate. Beta measures how much the fund moves with its benchmark (1.0 = in step); alpha is the return above what that beta would predict. Measured against the NAV of Kotak Nifty 50 Index Fund, standing in for the NIFTY 50 itself. A tracker's NAV is the index minus its running costs, so this compares funds against an investable benchmark rather than a costless one. Past performance does not guarantee future returns — not investment advice.
Top 10 holdings make up 29.9% of the portfolio · top 5 = 16.0%.
Equity holdings only, ISIN-verified, from Kotak Mahindra Mutual Fund's public monthly portfolio disclosure (Aug 2026). Not investment advice.
Weight = the position as a % of this fund's portfolio. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).